Patent suspension on the COVID-19 vaccine in Indonesian patent law perspective

References

• Adewopo, A. (2021). Access to pharmaceutical patents in the COVID-19 emergency: A case for government use in Nigeria. Journal of African Law, 65(S2), 259–10. https://doi.org/10.1017/S0021855321000334
   Google Scholar
• Adigwe, O. P., Oturu, D., & Kondreddy, S. (2022). The role of patent waivers and compulsory licensing in facilitating access to COVID-19 vaccines: Findings from a survey among healthcare practitioners in Nigeria. PLOS Global Public Health, 2(7), 1–11. https://doi.org/10.1371/journal.pgph.0000683
   Google Scholar
• Agreement on Trade-Related Aspects of Intellectual Property Rights. (1994) . Wto . (1994). Agreement Establishing the World Trade Organization.
   Google Scholar
• Chaudhuri, S., Dutta, M., Husain, Z., & Sinha, A. (2021). Patent protection and access to covid-19 medical products in developing countries. Indian Institute of Management Calcutta, 1–19. https://doi.org/10.2139/ssrn.3902314
   Google Scholar
• Chen, W. (2020). Promise and challenges in the development of COVID-19 vaccines. Human Vaccines & Immunotherapeutics, 16(11), 2604–2608. https://doi.org/10.1080/21645515.2020.1787067
   PubMed Web of Science ®Google Scholar
• Chin, E., & Chang, R. (2022). The WTO Waiver on COVID-19 Vaccine Patents. 76–99. https://perma.cc/6BH8-CMZA]
   Google Scholar
• Corona Virus Spread in Indonesia. (n.d.). Retrieved January 31, 2023, from https://news.google.com/covid19/map?hl=id&mid=%2Fm%2F03ryn&gl=ID&ceid=ID%3Aid
   Google Scholar
• Correa, C. (2000). Integrating Public Health Concerns into Patent Legislation in Developing Countries (R. Weissman, Ed.).
   Google Scholar
• Correa, C. M. (2002). Implications of the Doha declaration on the TRIPS agreement and public health.
   Google Scholar
• Correa, C. M. (2015). The use of compulsory licences in Latin America. MPI Studies on Intellectual Property and Competition Law, 22, 43–60. https://doi.org/10.1007/978-3-642-54704-1_3
   Google Scholar
• Crützen, S. J., & Kücking, M. (2021). The Waiver of Patent Protection for COVID-19 On Practicability and Purpose of Such Measure. Mayer Brown. https://www.mayerbrown.com/en/perspectives-events/publications/2021/07/ger-the-waiver-of-patent-protection
   Google Scholar
• Cui, J., Li, F., & Shi, Z. -L. (2019). Origin and Evolution of Pathogenic Coronaviruses. Nature Reviews Microbiology, 17(3), 181–192. https://doi.org/10.1038/s41579-018-0118-9
   PubMed Web of Science ®Google Scholar
• Djalante, R., Lassa, J., Setiamarga, D., Sudjatma, A., Indrawan, M., Haryanto, B., Mahfud, C., Sinapoy, M. S., Djalante, S., Rafliana, I., Gunawan, L. A., Surtiari, G. A. K., & Warsilah, H. (2020). Review and analysis of current responses to COVID-19 in Indonesia: Period of January to March 2020. Progress in Disaster Science, 6, 6. https://doi.org/10.1016/j.pdisas.2020.100091
   Google Scholar
• Dumpa, N., Goel, K., Guo, Y., McFall, H., Pillai, A. R., Shukla, A., Repka, M. A., & Murthy, S. N. (2019). Stability of Vaccines. AAPS Pharmaceutical Scientists Technology, 20(2), 42. https://doi.org/10.1208/s12249-018-1254-2
   PubMed Web of Science ®Google Scholar
• Eccleston-Turner, M., & Upton, H. (2021). International collaboration to ensure equitable access to vaccines for COVID-19: The ACT-Accelerator and the COVAX facility. The Milbank Quarterly, 99(2), 426–449. https://doi.org/10.1111/1468-0009.12503
   PubMed Web of Science ®Google Scholar
• Eslahtalab, A., Mahvelati Feyzabadi, M., Jajarmi Khayyat, H., Tohidipour, Z., Mohammadi, B., Mirzaei, M., Fazeli, F., M, E. A., Feyzabadi, M. M., Khayyat, J. H., & Professor, A. (2021). Reflection on the types of COVID-19 vaccines with emphasis on the side effects of vaccines; a review. Bulletin of Medical Sciences, 2(2), 183–198. https://doi.org/10.22034/MEB.2021.296265.1016
   Google Scholar
• Feichtner, I. (2009). The waiver power of the WTO: Opening the WTO for political debate on the reconciliation of competing interests. The European Journal of International Law, 20(3), 615–645. https://doi.org/10.1093/ejil/chp039
   Web of Science ®Google Scholar
• Iyabu, A. F. (2021). Foreign Minister Retno Marsudi: Abolition Of The Patent Rights For The COVID-19 Vaccine Is Very Crucial. https://voi.id/en/news/52351
   Google Scholar
• Katz, I. T., Weintraub, R., Bekker, L. -G., & Brandt, A. M. (2021). From vaccine nationalism to vaccine equity — finding a path forward. The New England Journal of Medicine, 384(14), 1281–1283. https://doi.org/10.1056/NEJMp2103614
   PubMed Web of Science ®Google Scholar
• Kementerian Kesehatan Republik Indonesia. (n.d.). Vaksinasi COVID-19 Nasional. January 31, 2023, from https://vaksin.kemkes.go.id/#/vaccines
   Google Scholar
• Lanoszka, A. (2003). The global politics of intellectual property rights and pharmaceutical drug policies in developing countries. International Political Science Review, 24(2), 181–197. https://doi.org/10.1177/0192512103024002002
   Web of Science ®Google Scholar
• Maskus, K. E. (2000). Intellectual property rights in the global economy. Columbia University Press.
   Google Scholar
• Mercurio, B. C. (2007). Resolving the public health crisis in the developing world: Problems and barriers of access to essential medicines. Northwestern Journal of International Human Rights, 5(1), 1–40. https://doi.org/10.2139/ssrn.980175
   Google Scholar
• Mercurio, B. C. (2021). WTO waiver from intellectual property protection for COVID-19 vaccines and treatments: A critical review. Virginia Journal of International Law Online, 62, 11–32. https://doi.org/10.2139/ssrn.3789820
   Google Scholar
• Meridith, S. (2021 , April22). Covid: Rich Countries are Refusing to Waive IP Rights on Vaccines. CNBC. https://www.cnbc.com/2021/04/22/covid-rich-countries-are-refusing-to-waive-ip-rights-on-vaccines.html
   Google Scholar
• Ministry of Investment (Badan Koordinasi Penanaman Modal). (n.d.). Investment Potential in Pharmaceutical Industry in Indonesia January 31, 2023, from https://www.bkpm.go.id/en/publication/detail/news/investment-potential-in-the-pharmaceutical-raw-material-industry-in-indones
   Google Scholar
• Morrow, T., & Felcone, L. H. (2004, September). Defining the difference: What makes biologics unique. Biotechnology Healthcare, 1(4), 24–29.
   PubMedGoogle Scholar
• Nichols, M. (2021 , May6). On Vaccinating the Globe, Blinken Warns: “We Have to Speed This Up” | Reuters. https://www.reuters.com/business/healthcare-pharmaceuticals/vaccinating-globe-blinken-warns-we-have-speed-this-up-2021-05-06/
   Google Scholar
• Nkomo, M. (2010). The under-utilization of TRIPs flexibility by developing countries: The case of Africa. World Trade Organization, 11, 125–138.
   Google Scholar
• Palmeter, D., & Mavroidis, P. C. (1998). The WTO legal system: Sources of law. The American Journal of International Law, 92(3), 398–413. https://doi.org/10.2307/2997915
   Web of Science ®Google Scholar
• Ranjan, P. (2021). The case for waiving intellectual property protection for covid-19 vaccines. Law of the Republic of Indonesia Number 14 Year 2001 regarding Patents , (2001)
   Google Scholar
• Sell, S. K., & Prakash, A. (2004). Using ideas strategically: The contest between business and NGO networks in intellectual property rights. International Studies Quarterly, 48(1), 143–175. https://doi.org/10.1111/j.0020-8833.2004.00295.x
   Web of Science ®Google Scholar
• Sitorus, W. (2014). Kepentingan Umum dalam Perlindungan Paten. Yuridika, 29(1). https://doi.org/10.20473/ydk.v29i1.357
   Google Scholar
• the South Centre. (2020). Message From the South Centre to the 73rd World Health Assembly. https://www.southcentre.int/wp-content/uploads/2020/05/WHA-73-Statement-SC-REV1-ENG.pdf
   Google Scholar
• Susilawati, S., Falefi, R., & Purwoko, A. (2020). Impact of COVID-19’s pandemic on the economy of Indonesia. Budapest International Research and Critics Institute (BIRCI-Journal): Humanities and Social Sciences, 3(2), 1147–1156. https://doi.org/10.33258/birci.v3i2.954
   Google Scholar
• Tahun. (2016). Undang-Undang No. 13. Tentang Paten.
   Google Scholar
• Tejomurti, K., Khaerah Pati, U., Pranoto, P., & Pati, U. K. (2020). Application of parallel importation and voluntary license in the covid-19 vaccines patent as a strategy for handling the health emergency situations in Indonesia. Tuah Law Journal, 4(2), 17–28. https://doi.org/10.30649/htlj.v4i2.13
   Google Scholar
• Thambisetty, S., McMahon, A., McDonagh, L., Kang, H. Y., & Dutfield, G. (2021). The TRIPS intellectual property waiver proposal: Creating the right incentives in patent law and politics to end the COVID-19 pandemic. SSRN Electronic Journal, 6. https://doi.org/10.2139/ssrn.3851737
   Google Scholar
• Thompson, V. A. (1965). Bureaucracy and innovation. Administrative Science Quarterly, 10(1), 1. https://doi.org/10.2307/2391646
   Web of Science ®Google Scholar
• UNICEF, UNDP, Prospera, & SMERU. (2021). Analysis of the social and economic impacts of COVID-19 on households and strategic policy recommendations for Indonesia.
   Google Scholar
• Wheaton, J. J. (1986). Generic competition and pharmaceutical innovation: The drug price competition and patent term restoration act of 1984. Catholic University Law Review, 35(2), 433.
   Web of Science ®Google Scholar
• World Health Organization. (2001). Network for Monitoring the Impact of Globalization and TRIPS on Access to Medicines. https://apps.who.int/iris/bitstream/handle/10665/67194/WHO_EDM_PAR_2002.1.pdf?sequence=1&isAllowed=y
   Google Scholar
• World Health Organization. (2020a). Coronavirus (COVID-19) Events as They Happen. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen
   Google Scholar
• World Health Organization. (2020b, October 20). Members Discuss Intellectual Property Response to the COVID-19 Pandemic. https://www.wto.org/english/news_e/news20_e/trip_20oct20_e.htm
   Google Scholar